These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 12675312)

  • 41. Analysis and stability study of temozolomide using capillary electrophoresis.
    Andrasi M; Bustos R; Gaspar A; Gomez FA; Klekner A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jul; 878(21):1801-8. PubMed ID: 20627825
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacokinetics of O6-benzylguanine and its active metabolite 8-oxo-O6-benzylguanine in plasma and cerebrospinal fluid after intrathecal administration of O6-benzylguanine in the nonhuman primate.
    Berg SL; Murry DJ; McCully CL; Godwin K; Balis FM
    Clin Cancer Res; 1998 Nov; 4(11):2891-4. PubMed ID: 9829757
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Plasma and cerebrospinal fluid pharmacokinetics of acivicin in Ommaya reservoir-bearing rhesus monkeys.
    McGovren JP; Stewart JC; Elfring GL; Smith RB; Soares N; Wood JH; Poplack DG; Von Hoff DD
    Cancer Treat Rep; 1982 Jun; 66(6):1333-41. PubMed ID: 7083237
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Plasma and cerebrospinal fluid pharmacokinetics of vincristine and vincristine sulfate liposomes injection (VSLI, marqibo®) after intravenous administration in Non-human primates.
    Shah NN; Cole DE; Lester-McCully CM; Wayne AS; Warren KE; Widemann BC
    Invest New Drugs; 2016 Feb; 34(1):61-5. PubMed ID: 26661090
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacokinetics of metronomic temozolomide in cerebrospinal fluid of children with malignant central nervous system tumors.
    Büsker S; Jäger W; Poschner S; Mayr L; Al Jalali V; Gojo J; Azizi AA; Ullah S; Bilal M; El Tabei L; Fuhr U; Peyrl A
    Cancer Chemother Pharmacol; 2022 May; 89(5):617-627. PubMed ID: 35355137
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development of a pharmacokinetic limited sampling model for temozolomide and its active metabolite MTIC.
    Kirstein MN; Panetta JC; Gajjar A; Nair G; Iacono LC; Freeman BB; Stewart CF
    Cancer Chemother Pharmacol; 2005 May; 55(5):433-8. PubMed ID: 15818507
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The plasma and cerebrospinal fluid pharmacokinetics of erlotinib and its active metabolite (OSI-420) after intravenous administration of erlotinib in non-human primates.
    Meany HJ; Fox E; McCully C; Tucker C; Balis FM
    Cancer Chemother Pharmacol; 2008 Aug; 62(3):387-92. PubMed ID: 17932674
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Irinotecan and temozolomide brain distribution: a focus on ABCB1.
    Goldwirt L; Beccaria K; Carpentier A; Farinotti R; Fernandez C
    Cancer Chemother Pharmacol; 2014 Jul; 74(1):185-93. PubMed ID: 24867782
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Plasma and cerebrospinal fluid pharmacokinetics of the Akt inhibitor, perifosine, in a non-human primate model.
    Cole DE; Lester-McCully CM; Widemann BC; Warren KE
    Cancer Chemother Pharmacol; 2015 May; 75(5):923-8. PubMed ID: 25740692
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of the cytotoxicity in vitro of temozolomide and dacarbazine, prodrugs of 3-methyl-(triazen-1-yl)imidazole-4-carboxamide.
    Tsang LL; Quarterman CP; Gescher A; Slack JA
    Cancer Chemother Pharmacol; 1991; 27(5):342-6. PubMed ID: 1998993
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of P-glycoprotein modulation with cyclosporin A on cerebrospinal fluid penetration of doxorubicin in non-human primates.
    Warren KE; Patel MC; McCully CM; Montuenga LM; Balis FM
    Cancer Chemother Pharmacol; 2000; 45(3):207-12. PubMed ID: 10663638
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacokinetics and cerebrospinal fluid penetration of phenylacetate and phenylbutyrate in the nonhuman primate.
    Berg S; Serabe B; Aleksic A; Bomgaars L; McGuffey L; Dauser R; Durfee J; Nuchtern J; Blaney S
    Cancer Chemother Pharmacol; 2001 May; 47(5):385-90. PubMed ID: 11391852
    [TBL] [Abstract][Full Text] [Related]  

  • 53. UV spectroscopic method for estimation of temozolomide: Application in stability studies in simulated plasma pH, degradation rate kinetics, formulation design, and selection of dissolution media.
    Waghule T; Narayan Saha R; Singhvi G
    Spectrochim Acta A Mol Biomol Spectrosc; 2021 Sep; 258():119848. PubMed ID: 33933945
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacodynamic-mediated reduction of temozolomide tumor concentrations by the angiogenesis inhibitor TNP-470.
    Ma J; Pulfer S; Li S; Chu J; Reed K; Gallo JM
    Cancer Res; 2001 Jul; 61(14):5491-8. PubMed ID: 11454697
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Plasma and cerebrospinal fluid pharmacokinetics of valproic acid after oral administration in non-human primates.
    Stapleton SL; Thompson PA; Ou CN; Berg SL; McGuffey L; Gibson B; Blaney SM
    Cancer Chemother Pharmacol; 2008 Apr; 61(4):647-52. PubMed ID: 17541590
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Plasma pharmacokinetics and cerebrospinal fluid penetration of hypericin in nonhuman primates.
    Fox E; Murphy RF; McCully CL; Adamson PC
    Cancer Chemother Pharmacol; 2001; 47(1):41-4. PubMed ID: 11221960
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Development and validation of simple step protein precipitation UHPLC-MS/MS methods for quantitation of temozolomide in cancer patient plasma samples.
    El Mubarak MA; Stylos EK; Chatziathanasiadou MV; Danika C; Alexiou GA; Tsekeris P; Renziehausen A; Crook T; Syed N; Sivolapenko GB; Tzakos AG
    J Pharm Biomed Anal; 2019 Jan; 162():164-170. PubMed ID: 30243056
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Temozolomide in malignant gliomas.
    Yung WK
    Semin Oncol; 2000 Jun; 27(3 Suppl 6):27-34. PubMed ID: 10866347
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Plasma pharmacokinetics and cerebrospinal fluid penetration of thioguanine in children with acute lymphoblastic leukemia: a collaborative Pediatric Oncology Branch, NCI, and Children's Cancer Group study.
    Lowe ES; Kitchen BJ; Erdmann G; Stork LC; Bostrom BC; Hutchinson R; Holcenberg J; Reaman GH; Woods W; Franklin J; Widemann BC; Balis FM; Murphy RF; Adamson PC
    Cancer Chemother Pharmacol; 2001 Mar; 47(3):199-205. PubMed ID: 11320662
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacokinetics of dacarbazine (DTIC) in pregnancy.
    Kantrowitz-Gordon I; Hays K; Kayode O; Kumar AR; Kaplan HG; Reid JM; Safgren SL; Ames MM; Easterling TR; Hebert MF
    Cancer Chemother Pharmacol; 2018 Mar; 81(3):455-460. PubMed ID: 29305638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.